title: Acute oxygen supplementation does not relieve the impairment of respiratory muscle strength in hypoxemic COPD.
abstract: OBJECTIVE
  To verify whether hypoxemia affects respiratory muscle strength in the absence of malnutrition and whether such effect, if present, is reversible with an acute oxygen supplementation.
  
  
  METHODS
  Case series analysis, before-after trial.
  
  
  METHODS
  Outpatient pneumology departments of two university hospitals.
  
  
  METHODS
  One hundred twenty patients affected by COPD in stable conditions having actual to ideal body weight ratio of > or =90%.
  
  
  RESULTS
  Maximal inspiratory pressure (MIP) was measured at functional residual capacity level in the whole sample of subjects and during oxygen supplementation in 58 patients having a PaO2< or =60 mm Hg when breathing in room air. Predictors of MIP were assessed by a multivariate analysis. MIP values before and after oxygen supplementation were compared by a paired t test. MIP was independently correlated with FVC (p<0.001), PaO2 (p<0.01), and age (p<0.01). In the subgroup of hypoxemic patients, MIP values did not change significantly after oxygen supplementation (3.08+/-1.74 vs 3.03+/-1.91 kPa, t=0.43, not significant).
  
  
  CONCLUSIONS
  Hypoxemia is an important negative correlate of MIP even in well-nourished COPD patients. Its effect is not reversible with an acute oxygen supplementation.
authors.affiliation: Department of Geriatrics, Catholic University, Rome, Italy.
authors.forename: R A
authors.initials: RA
authors.lastname: Incalzi
authors.forename: L
authors.initials: L
authors.lastname: Fuso
authors.forename: T
authors.initials: T
authors.lastname: Ricci
authors.forename: S
authors.initials: S
authors.lastname: Sammarro
authors.forename: A
authors.initials: A
authors.lastname: Dicorcia
authors.forename: A
authors.initials: A
authors.lastname: Albano
authors.forename: R
authors.initials: R
authors.lastname: Pistelli
mesh_terms: D000367:Age Factors; D000368:Aged; D001835:Body Weight; D005260:Female; D005500:Follow-Up Studies; D005544:Forecasting; D005652:Functional Residual Capacity / Q000502:physiology; D006801:Humans; D000860:Hypoxia / Q000503:physiopathology* / Q000628:therapy; D001239:Inhalation / Q000502:physiology; D008173:Lung Diseases, Obstructive / Q000503:physiopathology* / Q000628:therapy; D008297:Male; D015999:Multivariate Analysis; D009119:Muscle Contraction / Q000502:physiology*; D009748:Nutrition Disorders; D009752:Nutritional Status; D010100:Oxygen / Q000097:blood; D010102:Oxygen Inhalation Therapy; D011312:Pressure; D012044:Regression Analysis; D012115:Residual Volume / Q000502:physiology; D012132:Respiratory Muscles / Q000503:physiopathology*; D014109:Total Lung Capacity / Q000502:physiology; D014797:Vital Capacity / Q000502:physiology
chemical_list: D010100:Oxygen